TPD & Induced Proximity Summit Leaderboard
  • Friday, July 24, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 621

Author

Pharma Journalist 8947 posts 0 comments

Goldfinch Bio initiates phase 1 clinical trial of GFB-887 for kidney disease

Jun 6, 2019
Goldfinch Bio, Inc., a biotechnology company focused on developing precision therapies for patients with kidney diseases, announced it has initiated dosing in a Phase 1 clinical trial…
Read More...

Innovation Pharma Signs Agreement for Advanced Oral Tablet Technology in Treating Inflammatory Bowel…

Jun 6, 2019
Innovation Pharmaceuticals, a clinical stage biopharmaceutical company, has signed an agreement with BDD Pharma, an award-winning drug delivery company specializing in modified and…
Read More...

Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development…

Jun 6, 2019
Servier, an international independent pharmaceutical company, and Yposkesi, a leading CDMO for gene therapy viral vector manufacturing, announce that they have signed a manufacturing…
Read More...

Advanced Accelerator Applications Receives Positive CHMP Opinion for LysaKare

Jun 6, 2019
Advanced Accelerator Applications S.A. (AAA), a Novartis company, announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted…
Read More...

PeptiDream Announces Strategic Partnership with Drug-Delivery Expert PharmaIN

Jun 5, 2019
PeptiDream Inc., a public Kanagawa-based biopharmaceutical company announced a strategic partnership with Seattle-based PharmaIN Corporation for the purpose of investigating the use of…
Read More...

CStone received approval to initiate clinical development in China of CS1001 and BLU-554 (CS3008) in…

Jun 5, 2019
CStone Pharmaceuticals announced that it has received approval to initiate clinical development in China of CS1001 in combination with BLU-554 (CS3008) in patients with locally advanced…
Read More...

Reata Receives Orphan Drug Designation for Bardoxolone Methyl for the Treatment of Autosomal…

Jun 5, 2019
Reata Pharmaceuticals, Inc. announced the United States Food and Drug Administration (FDA) has granted orphan drug designation to bardoxolone methyl (bardoxolone) for the treatment of…
Read More...

Evotec and Celgene further expand iPSC collaboration including new cell type

Jun 5, 2019
Evotec SE announced that its strategic alliance with Celgene Corporation has been expanded to include a new cell type triggering a payment of $ 9.0 m to Evotec. Evotec and Celgene…
Read More...

Registration opens for SMi’s 3rd Annual Ophthalmic Drugs Conference and Focus Day

Jun 5, 2019
SMi reports: Registration is now open for the 3rd annual Ophthalmic Drugs Conference and Focus Day, taking place in London this November The global ophthalmic drug market size is…
Read More...

Sterling announces pilot plant facility expansion is operational

Jun 5, 2019
Contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions has announced the expansion of its pilot plant facility is now operational at its UK site following…
Read More...
Prev Next
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Organon Expands Australia Biosimilar Partnership With Samsung Bioepis
  • Telix Opens Advanced Cancer Radiopharmaceutical Facility in Melbourne
  • FDA Approves First Oral PCSK9 Inhibitor for High Cholesterol
  • FDA Grants Full Approval to Fabhalta for IgA Nephropathy
  • EU Approves Wegovy Pill for Obesity Treatment

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.